Precision public health: Mapping socioeconomic disparities in opioid dispensations at Swedish pharmacies by Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA)
Fig 1
We began with all individuals registered in Sweden on December 31, 2011, and excluded children, those with a cancer diagnosis, a pain diagnosis, or a previous substance use disorder diagnosis during 2010, as well as a small number of individuals with missing sociodemographic data.